vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and GCM Grosvenor Inc. (GCMG). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $177.1M, roughly 1.2× GCM Grosvenor Inc.). GCM Grosvenor Inc. runs the higher net margin — 32.8% vs 8.3%, a 24.6% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 7.2%). GCM Grosvenor Inc. produced more free cash flow last quarter ($175.0M vs $122.4M). Over the past eight quarters, GCM Grosvenor Inc.'s revenue compounded faster (27.5% CAGR vs 19.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.

COLL vs GCMG — Head-to-Head

Bigger by revenue
COLL
COLL
1.2× larger
COLL
$205.4M
$177.1M
GCMG
Growing faster (revenue YoY)
COLL
COLL
+5.8% gap
COLL
12.9%
7.2%
GCMG
Higher net margin
GCMG
GCMG
24.6% more per $
GCMG
32.8%
8.3%
COLL
More free cash flow
GCMG
GCMG
$52.7M more FCF
GCMG
$175.0M
$122.4M
COLL
Faster 2-yr revenue CAGR
GCMG
GCMG
Annualised
GCMG
27.5%
19.1%
COLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
GCMG
GCMG
Revenue
$205.4M
$177.1M
Net Profit
$17.0M
$58.2M
Gross Margin
62.5%
Operating Margin
29.6%
30.9%
Net Margin
8.3%
32.8%
Revenue YoY
12.9%
7.2%
Net Profit YoY
35.3%
149.2%
EPS (diluted)
$0.48
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
GCMG
GCMG
Q4 25
$205.4M
$177.1M
Q3 25
$209.4M
$135.0M
Q2 25
$188.0M
$119.7M
Q1 25
$177.8M
$125.8M
Q4 24
$181.9M
$165.3M
Q3 24
$159.3M
$122.9M
Q2 24
$145.3M
$117.0M
Q1 24
$144.9M
$108.9M
Net Profit
COLL
COLL
GCMG
GCMG
Q4 25
$17.0M
$58.2M
Q3 25
$31.5M
$10.5M
Q2 25
$12.0M
$15.4M
Q1 25
$2.4M
$463.0K
Q4 24
$12.5M
$7.6M
Q3 24
$9.3M
$4.2M
Q2 24
$19.6M
$4.8M
Q1 24
$27.7M
$2.1M
Gross Margin
COLL
COLL
GCMG
GCMG
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
GCMG
GCMG
Q4 25
29.6%
30.9%
Q3 25
29.7%
32.7%
Q2 25
18.7%
16.1%
Q1 25
12.2%
12.2%
Q4 24
20.9%
26.4%
Q3 24
21.9%
20.3%
Q2 24
32.7%
17.8%
Q1 24
34.1%
-14.7%
Net Margin
COLL
COLL
GCMG
GCMG
Q4 25
8.3%
32.8%
Q3 25
15.0%
7.8%
Q2 25
6.4%
12.9%
Q1 25
1.4%
0.4%
Q4 24
6.9%
4.6%
Q3 24
5.9%
3.4%
Q2 24
13.5%
4.1%
Q1 24
19.1%
2.0%
EPS (diluted)
COLL
COLL
GCMG
GCMG
Q4 25
$0.48
$0.23
Q3 25
$0.84
$0.16
Q2 25
$0.34
$0.05
Q1 25
$0.07
$-0.02
Q4 24
$0.36
$0.09
Q3 24
$0.27
$0.03
Q2 24
$0.52
$0.04
Q1 24
$0.71
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
GCMG
GCMG
Cash + ST InvestmentsLiquidity on hand
$386.7M
$242.1M
Total DebtLower is stronger
$428.4M
Stockholders' EquityBook value
$301.7M
$27.0M
Total Assets
$1.7B
$813.8M
Debt / EquityLower = less leverage
15.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
GCMG
GCMG
Q4 25
$386.7M
$242.1M
Q3 25
$285.9M
$182.7M
Q2 25
$222.2M
$136.3M
Q1 25
$197.8M
$94.5M
Q4 24
$162.8M
$89.5M
Q3 24
$120.0M
$98.4M
Q2 24
$271.6M
$73.9M
Q1 24
$318.0M
$41.9M
Total Debt
COLL
COLL
GCMG
GCMG
Q4 25
$428.4M
Q3 25
$429.3M
Q2 25
$430.2M
Q1 25
$431.1M
Q4 24
$432.0M
Q3 24
$432.9M
Q2 24
$433.8M
Q1 24
$384.0M
Stockholders' Equity
COLL
COLL
GCMG
GCMG
Q4 25
$301.7M
$27.0M
Q3 25
$274.8M
$-7.4M
Q2 25
$232.2M
$-12.3M
Q1 25
$234.4M
$-28.3M
Q4 24
$228.8M
$-27.6M
Q3 24
$234.3M
$-31.9M
Q2 24
$216.6M
$-28.5M
Q1 24
$222.2M
$-26.4M
Total Assets
COLL
COLL
GCMG
GCMG
Q4 25
$1.7B
$813.8M
Q3 25
$1.6B
$685.9M
Q2 25
$1.6B
$636.9M
Q1 25
$1.6B
$579.8M
Q4 24
$1.7B
$612.7M
Q3 24
$1.6B
$575.0M
Q2 24
$1.1B
$543.9M
Q1 24
$1.1B
$497.3M
Debt / Equity
COLL
COLL
GCMG
GCMG
Q4 25
15.87×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
GCMG
GCMG
Operating Cash FlowLast quarter
$123.0M
$183.5M
Free Cash FlowOCF − Capex
$122.4M
$175.0M
FCF MarginFCF / Revenue
59.6%
98.8%
Capex IntensityCapex / Revenue
0.3%
4.8%
Cash ConversionOCF / Net Profit
7.25×
3.16×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$326.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
GCMG
GCMG
Q4 25
$123.0M
$183.5M
Q3 25
$78.4M
$79.8M
Q2 25
$72.4M
$42.0M
Q1 25
$55.4M
$33.3M
Q4 24
$84.6M
$148.8M
Q3 24
$-9.0M
$69.0M
Q2 24
$67.4M
$17.5M
Q1 24
$61.9M
$24.2M
Free Cash Flow
COLL
COLL
GCMG
GCMG
Q4 25
$122.4M
$175.0M
Q3 25
$78.3M
$78.3M
Q2 25
$72.4M
$40.8M
Q1 25
$54.6M
$32.1M
Q4 24
$84.1M
$132.0M
Q3 24
$-9.2M
$62.2M
Q2 24
$67.1M
$12.8M
Q1 24
$61.4M
$20.0M
FCF Margin
COLL
COLL
GCMG
GCMG
Q4 25
59.6%
98.8%
Q3 25
37.4%
58.0%
Q2 25
38.5%
34.1%
Q1 25
30.7%
25.5%
Q4 24
46.2%
79.9%
Q3 24
-5.8%
50.6%
Q2 24
46.2%
10.9%
Q1 24
42.3%
18.4%
Capex Intensity
COLL
COLL
GCMG
GCMG
Q4 25
0.3%
4.8%
Q3 25
0.1%
1.1%
Q2 25
0.0%
1.0%
Q1 25
0.4%
0.9%
Q4 24
0.3%
10.1%
Q3 24
0.2%
5.5%
Q2 24
0.2%
4.0%
Q1 24
0.4%
3.9%
Cash Conversion
COLL
COLL
GCMG
GCMG
Q4 25
7.25×
3.16×
Q3 25
2.49×
7.61×
Q2 25
6.05×
2.72×
Q1 25
22.92×
71.84×
Q4 24
6.75×
19.54×
Q3 24
-0.96×
16.60×
Q2 24
3.44×
3.64×
Q1 24
2.23×
11.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

GCMG
GCMG

Asset Management1$108.6M61%
Management Service Incentive Performance Fees$61.7M35%
Management Service Incentive Carried Interest$5.1M3%
Service Other$1.8M1%

Related Comparisons